GlassScriptPhysician profile
Mina S Khan
NPI 1215095559
$2,393.39
in general payments reported to CMS, 2019-2025
22 companies · $255 in 2025
The $255 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $316 · 2020: $408 · 2021: $793 · 2022: $284 · 2023: $213 · 2024: $125 · 2025: $255.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $592.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $481.44 | 2019-2025 | Jardiance, Trijardy Xr, Synjardy |
| Novo Nordisk INC | $273.61 | 2020-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $272.06 | 2019-2025 | Trelegy Ellipta |
| Astrazeneca Pharmaceuticals LP | $235.17 | 2019-2025 | Breztri, Farxiga |
| Lilly USA, LLC | $211.32 | 2019-2024 | Mounjaro |
| Sanofi-Aventis U.S. LLC | $175.19 | 2019-2022 | |
| Dexcom, INC. | $123.32 | 2021-2025 | Dexcom G6 Transmitter |
| Abbvie INC. | $78.45 | 2021-2022 | |
| Radius Health, INC. | $66.17 | 2019 | |
| Abbott Laboratories | $65.35 | 2021-2023 | Freestyle Libre 2 |
| Amgen INC. | $59.11 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.97 | 2025 | |
| Astellas Pharma US INC | $50.09 | 2019-2021 | |
| Esperion Therapeutics, INC. | $49.92 | 2020-2021 | |
| Medtronic, INC. | $44.93 | 2021-2025 | Thunder, Minimed 780g |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $30.18 | 2019-2021 | |
| Sanofi Pasteur INC. | $29.28 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $27.11 | 2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.37 | 2025 | Caplyta |
| Exact Sciences Corporation | $20.35 | 2024 | Cologuard Collection Kit |
| Otsuka America Pharmaceutical, INC. | $18.00 | 2023 | Rexulti |
| Allergan, INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mina Khan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.